Nussara Pakvisal

Years Active: 2022-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Sutima Luangdilok, Passakorn Wanchaijiraboon, Nussara Pakvisal, Thiti Susiriwatananont, Nicha Zungsontiporn, Virote Sriuranpong, Panot Sainamthip, Nungruthai Suntronwong, Preeyaporn Vichaiwattana, Nasamon Wanlapakorn, Yong Poovorawan, Nattaya Teeyapun, Suebpong Tanasanvimon
Immunogenicity after a Third COVID-19 mRNA Booster in Solid Cancer Patients Who Previously Received the Primary Heterologous CoronaVac/ChAdOx1 Vaccine. Vaccines 10 (10) (2022)
Chanchai Charonpongsuntorn, Suebpong Tanasanvimon, Krittiya Korphaisarn, Songwit Payapwattanawong, Teerada Siripoon, Nussara Pakvisal, Jitlada Juengsamarn, Ekkamol Phaibulvatanapong, Jarin Chindaprasirt, Naiyarat Prasongsook, Kittipong Udomdamrongkul, Nuttapong Ngamphaiboon, Ekaphop Sirachainan
Efficacy, Safety, and Patient-Reported Outcomes of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Thailand: A Multicenter Prospective Study. JCO global oncology 8 (2022)
Passakorn Wanchaijiraboon, Nattaya Teeyapun, Nussara Pakvisal, Panot Sainamthip, Thiti Susiriwatananont, Nicha Zungsontiporn, Nungruthai Suntronwong, Preeyaporn Vichaiwattana, Worata Klinsawat, Nasamon Wanlapakorn, Suebpong Tanasanvimon, Virote Sriuranpong, Yong Poovorawan, Sutima Luangdilok
Durability of Immune Response to ChAdOx1-nCoV-19 Vaccine in Solid Cancer Patients Undergoing Anticancer Treatment. Vaccines 10 (10) (2022)

Nussara Pakvisal.css-eqlu8i{font-size:small;padding-left:4px;}